항생제 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00003406
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 161
Buy Now

항생제 시장은 2020년에 441억 1131만 달러였으며 2028년에는 592억 5324만 달러에 이를 것으로 예상됩니다. 2021-2028년 동안 4.0%의 CAGR로 성장할 것으로 예상됩니다.



항생제는 박테리아 감염 및 질병에 대항하는 데 사용되는 강력한 의약품입니다. 이들은 특히 Staph., Strep. 또는 E. coli와 같은 박테리아에 의해 발생하는 감염을 치료하는 데 사용됩니다. 항생제는 박테리아를 죽이거나(살균) 번식과 성장을 제한합니다(정균). 항생제 시장은 바이러스 감염에 대해 작동하지 않습니다. 항생제로 치료되는 일반적인 감염에는 결막염, 피부 또는 연조직 감염, 상기도 감염, 기관지염, 연쇄상 구균 인두염(패혈성 인두염) 등이 있습니다.



수익성 있는 지역 항생제 시장




시장 통찰력



제네릭 의약품 개발 증가



제네릭 의약품은 더 오래 특허를 받았습니다. 제네릭 버전은 비용 효율적인 약물을 제공하고 다양한 경제 계층에 속하는 사람들에게 이러한 약물의 도달 범위를 늘리기 위한 목적으로 시장에 출시됩니다. 일반 버전은 가용성과 경제성으로 인해 인기가 있습니다. 예를 들어, 2018년 NCBI에 발표된 연구에 따르면 평균 브랜드 처방 가격은 평균 제네릭 가격의 거의 4배였습니다. 또한 회사는 최소한의 비용으로 항생제를 제공하기 위해 제네릭 버전 개발에 주력하고 있습니다. 예를 들어, 2018년 6월 Lupine은 미국 시장에서 제네릭 토브라마이신 흡입 솔루션을 출시했습니다. 또한 정부 당국의 장려도 제네릭 항생제 생산을 촉진할 것으로 예상되며, 이는 결국 예측 기간 동안 항생제 시장의 성장을 견인할 것입니다. 예를 들어, 2019년 2월 미국 식품의약국(US FDA)은 미국에서 인도 제약 회사가 제조한 제네릭 의약품의 상업화 승인을 발표했습니다.

검사 유형 통찰력



항생제 시장은 약물 등급에 따라 설폰아미드, 아미노글리코사이드, 카바페넴, 마크롤라이드, 플루오로퀴놀론, 페니실린, 세팔로스포린 등으로 분류됩니다. 세팔로스포린 부문은 2020년에 시장에서 가장 큰 점유율을 차지했습니다. 반면 플루오로퀴놀론 세그먼트는 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.



글로벌 항생제 시장, 제품 유형별 – 2020 및 2028


< /h3>

Action-Mechanism Insights



항생제 시장은 작용기전을 기반으로 마이콜산 억제제, RNA 합성 억제제, DNA 합성 억제제, 단백질 합성 억제제, 세포벽 합성 억제제로 세분화되었습니다. . 세포벽 합성 억제제 부문은 2020년에 시장에서 가장 큰 점유율을 차지한 반면, DNA 합성 억제제 부문은 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 추정됩니다.



전략적 통찰력



제품 출시 및 승인 전략은 기업이 전 세계적으로 입지와 제품 포트폴리오를 확장하고 증가하는 수요를 충족하기 위해 일반적으로 채택합니다.



항생제 시장에서 활동하는 시장 참여자는 고객 확대를 위해 확장 전략을 채택합니다. 전 세계에 기반을 두어 플레이어가 브랜드 이름을 전 세계적으로 유지할 수 있습니다. 예를 들어, 2019년 7월 Pfizer와 같은 회사는 8개의 생명 공학 파트너 및 유럽 학계와 협력하여 새로운 결핵 항생제를 발견하고 개발하기 위한 국제 연구 컨소시엄을 시작했습니다.



글로벌 항생제 시장 - 약물 등급별< /p>



  • 세팔로스포린

  • 페니실린

  • 플루오로퀴놀론

  • 마크로라이드

  • 카바페넴

  • 아미노글리코사이드

  • 설폰아미드

  • 기타


글로벌 항생제 시장 – 작용 메커니즘별





  • 세포벽 합성 억제제





    • li>
    • 단백질 합성 억제제

    • DNA 합성 억제제

    • RNA 합성 억제제

    • 마이콜산 억제제

    • 기타


    글로벌 항생제 - 지역별





    • 북미


      • 미국

      • 캐나다

      • 멕시코


    • 유럽


      • 프랑스

      • 독일

      • 이탈리아

      • 영국

      • 스페인

      • 기타 유럽



    • 아시아 태평양(APAC)


      • 중국

      • 인도
      • 대한민국

      • 일본

      • 호주

      • 기타 아시아 태평양



    • 중동 및 아프리카(MEA)


      • 남아프리카

      • 사우디아라비아

      • UAE

      • 나머지 중동 및 아프리카


    • 남미


      • 브라질

      • 아르헨티나

      • 남미 기타 지역



    • 회사 프로필





      • Pfizer, Inc

      • Johnson & Johnson Services, Inc.(Janssen Pharmaceuticals),

      • Abbott,
      • GlaxoSmithKline Plc,

      • Sanofi,

      • Novartis AG,

      • Bayer AG,

      • Bristol Myers Squibb Company,< /li>
      • Eli Lilly and Company,

      • Astellas Pharma


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional analysis in terms of antibiotics?

The North American region holds the largest market for the breast cancer screening. The United States held the largest market for antibiotics market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer , growing developments for screening and imaging process by the companies and others.

What are the driving factors for antibiotics market across the globe?

The growth of the market is attributed to some key driving factors such as rising prevalence of bacterial infections, growing geriatric population and increasing development of generic drugs. However, tedious and expensive process of antibiotic development is expected to restraint the growth of the market during the forecast years.

What are antibiotics ?

Antibiotics are powerful medicines that are used to fight against bacterial infections. Antibiotics are also known as antibacterials which include a range of powerful drugs and are used to treat diseases caused by bacteria. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. and either kill the bacteria (bactericidal) or keep it from reproducing and growing (bacteriostatic). The antibiotics do not work against any viral infection. Some common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat) and among others.

The List of Companies - Antibiotics Market

  1. Pfizer, Inc
  2. Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
  3. Abbott,
  4.  GlaxoSmithKline Plc,
  5. Sanofi,
  6.  Novartis AG,
  7.  Bayer AG,
  8. Bristol Myers Squibb Company,
  9. Eli Lilly and Company,
  10. Astellas Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports